Carmen R. Rodriguez
General Counsel at ANACOR PHARMACEUTICALS INC
Network origin in Carmen R. Rodriguez first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Subsidiary | Pharmaceuticals: Major | 25 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Carmen R. Rodriguez via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| ABBOTT LABORATORIES | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal | |
| MERCK & CO., INC. | Pharmaceuticals: Major | President Public Communications Contact | |
| MERRILL LYNCH PREFERRED CAPITAL TRUST I | Major Banks | Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal General Counsel Corporate Officer/Principal Corporate Officer/Principal General Counsel | |
| MEDICIS PHARMACEUTICAL CORP | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal | |
| ARRAY TECHNOLOGIES, INC. | Pharmaceuticals: Major | President Director/Board Member Director/Board Member | |
ARCH Venture Partners LLC
 ARCH Venture Partners LLC Investment ManagersFinance ARCH Venture Partners LLC is a Venture Capital firm founded in 1986. The firm is headquartered in Chicago with additional office in Dublin. | Investment Managers | Private Equity Analyst Private Equity Investor | |
Jazz Pharmaceuticals, Inc.
 Jazz Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Jazz Pharmaceuticals, Inc. develops and markets pharmaceutical products. Its medical products include xyrem, erwinaze, vyxeos, and kidrolas. The company was founded by Bruce C. Cozadd in 2003 and is headquartered in Palo Alto, CA. | Pharmaceuticals: Major | Director/Board Member | |
| KYTHERA BIOPHARMACEUTICALS INC | Pharmaceuticals: Major | Founder | |
InteKrin Therapeutics, Inc.
 InteKrin Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology InteKrin Therapeutics, Inc. develops and commercializes therapeutics for metabolic and immune disorders. It develops therapeutics for diabetes, insulin resistance and multiple sclerosis. The company was founded by Dennis M. Lanfear and Christos S. Mantzoros in 2005 and is headquartered in Palo Alto, CA. | Pharmaceuticals: Major | Corporate Officer/Principal Sales & Marketing | |
| NGM BIOPHARMACEUTICALS, INC. | Biotechnology | Director/Board Member Chairman | |
Epirium Bio, Inc.
 Epirium Bio, Inc. Pharmaceuticals: MajorHealth Technology Epirium Bio, Inc. develops therapeutics for orphan and rare diseases characterized by impairment of the skeletal muscle, cardiac and neuronal systems. The company was founded in 2008 by Alan Stewart Maisel, Sundeep Dugar, and Francisco Villarreal and is headquartered in Los Altos Hills, CA. | Pharmaceuticals: Major | Chairman | |
| NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal Sales & Marketing | |
| GSK PLC | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
Duke University
 Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Undergraduate Degree Doctorate Degree | |
| BOTANIX PHARMACEUTICALS LIMITED | Pharmaceuticals: Major | Chairman Chief Executive Officer | |
| AFFYMAX, INC. | Biotechnology | Director/Board Member | |
Care Capital LLC
 Care Capital LLC Investment ManagersFinance Care Capital LLC (care capital) is a venture capital firm founded in 2001 by Jan Leschly and David Ramsay. The firm is headquartered in Princeton, New Jersey. | Investment Managers | Private Equity Investor | |
| ARYX THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| XENOPORT, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member President | |
| University of California, Los Angeles | College/University | Undergraduate Degree | |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Undergraduate Degree Undergraduate Degree | |
| University of California, Berkeley | College/University | Doctorate Degree Undergraduate Degree Graduate Degree | |
| University of Illinois | College/University | Undergraduate Degree | |
| University of Maryland | College/University | Undergraduate Degree | |
| NEPHROGENEX INC | Medical Distributors | Director/Board Member Chairman | |
| MEDIVATION INC | Pharmaceuticals: Major | President Director/Board Member Director/Board Member | |
| Gordon Research Conferences | Chairman | ||
Amgen Europe BV
 Amgen Europe BV Medical DistributorsDistribution Services Part of Amgen, Inc., Amgen Europe BV wholesales pharmaceutical products. The private company is based in Breda, Netherlands. | Medical Distributors | Corporate Officer/Principal | |
Infectious Disease Research Institute
 Infectious Disease Research Institute Miscellaneous Commercial ServicesCommercial Services Infectious Disease Research Institute operates as a innovative science to research and development company. It offers pipeline, adjuvants, vaccines, diagnostics and drugs products. The firm also provides manufacturing, analytical methods, stability studies, process and contact services. The company was founded by Steven G. Reed in 1993 and is headquartered in Seattle, WA. | Miscellaneous Commercial Services | Director/Board Member Chairman | |
| BAUSCH HEALTH COMPANIES INC. | Pharmaceuticals: Other | Corporate Officer/Principal Corporate Officer/Principal | |
ViiV Healthcare Ltd.
 ViiV Healthcare Ltd. Pharmaceuticals: MajorHealth Technology ViiV Healthcare Ltd. manufactures and distributes pharmaceutical products. Its medicine include Triumeq, Tivicay, Selzentry, Celesentri, Epzicom, Kivexa, Ziagen, Trizivir, Combivir, Retrovir AZT, Lexiva, Telzir, Viracept and Rescriptor. The company was founded in 2009 and is headquartered in Brentford, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Stanford Graduate School of Business | College/University | Masters Business Admin Masters Business Admin | |
BlackThorn Therapeutics, Inc.
 BlackThorn Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Blackthorn Therapeutics, Inc. manufactures and markets medicines for neuro developmental disorders. The company is headquartered in San Francisco, CA. | Pharmaceuticals: Major | Chief Executive Officer | |
| UNITY BIOTECHNOLOGY, INC. | Biotechnology | Director/Board Member Chairman | |
Dermavant Sciences, Inc.
 Dermavant Sciences, Inc. BiotechnologyHealth Technology Part of Roivant Sciences Ltd., Dermavant Sciences, Inc. develops biological products. The private company is based in Raleigh, NC. Todd Zavodnick has been the CEO of the company since 2018. | Biotechnology | President Corporate Officer/Principal | |
Scope Markets Ltd.
 Scope Markets Ltd. Investment Banks/BrokersFinance Part of Rostro Financials Group Ltd., Scope Markets Ltd. provides forex securities brokerage services. The private company is based in Belize City, Belize. The CEO of the Belizean company is Jacob John Plattner. Scope Markets was acquired by Rostro Financials Group Ltd. on January 09, 2023. | Investment Banks/Brokers | Chief Executive Officer | |
Better Therapeutics LLC
 Better Therapeutics LLC Medical SpecialtiesHealth Technology Part of Better Therapeutics, Inc., Better Therapeutics LLC is a private company that focuses on clinical development and creating habits that heal to reduce the need for other treatments. The company is based in San Francisco, CA. The company is pioneers in the field of prescription digital therapeutics for treating a range of cardiometabolic diseases. The company was founded by David P. Perry and Kevin J. Appelbaum. Kevin J. Appelbaum has been the CEO of the company since 2015. Better Therapeutics was acquired by Mountain Crest Acquisition Corp. II on October 28, 2021 for $164.55 million. | Medical Specialties | Founder Director/Board Member | |
| VIATRIS INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
| AN2 THERAPEUTICS, INC. | Biotechnology | Corporate Officer/Principal Director of Finance/CFO Founder | |
Mc2 Therapeutics AS
 Mc2 Therapeutics AS Pharmaceuticals: MajorHealth Technology Mc2 Therapeutics is a Danish commercial stage biotech company that focuses on developing novel treatment paradigms for immune-mediated and inflammatory diseases. Mc2 Therapeutics is based in Denmark, specifically in Hørsholm, and has subsidiaries in the United Kingdom. The company is privately held and is developing a new standard of topical therapies for chronic inflammatory conditions using PAD™ technology. The company aims to release the full potential of novel topical drugs for the benefit of patients, physicians, payers, and societies. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| ARCUTIS BIOTHERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Compliance Officer | |
| BETTER THERAPEUTICS, INC. | Medical Specialties | Founder Director/Board Member | |
EQRx International, Inc.
 EQRx International, Inc. Pharmaceuticals: MajorHealth Technology EQRx International, Inc. engages in healthcare services. The firm specializes in remaking medicine services. The company was founded by Peter Bach and Sandra Horning on January 12, 2020 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member | |
Fochon Pharmaceuticals Ltd.
 Fochon Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Part of Shanghai Fosun Pharmaceutical (Group) Co., Ltd., Fochon Pharmaceuticals Ltd. is a Chinese pharmaceutical company that develops small molecule drugs. The private company is based in Chongqing, China. Fochon Pharmaceuticals was founded in 2009 by Wei Bo Wang. | Pharmaceuticals: Major | Director/Board Member | |
RBNC Therapeutics, Inc.
 RBNC Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology RBNC Therapeutics, Inc. develops and commercializes therapies for individuals with brain diseases. | Pharmaceuticals: Major | Chairman | |
| LYELL IMMUNOPHARMA, INC. | Biotechnology | Director/Board Member | |
Lycia Therapeutics, Inc.
 Lycia Therapeutics, Inc. BiotechnologyHealth Technology Lycia Therapeutics, Inc. is a biotechnology company, which engages in the developing technology that utilizes lysosome-targeting chimeras. It uses LYTACs platform to discover and provide therapeutics that degrade extracellular and membrane-bound proteins that drive a range of difficult-to treat diseases, including cancers and autoimmune conditions. The company was founded by Carolyn R. Bertozzi in 2019 and is headquartered in San Diego, CA. | Biotechnology | Director/Board Member |
Statistics
International
| United States | 42 |
| Switzerland | 3 |
| United Kingdom | 3 |
| Australia | 2 |
| Netherlands | 2 |
Sectoral
| Health Technology | 36 |
| Consumer Services | 8 |
| Finance | 5 |
| Distribution Services | 3 |
| Commercial Services | 2 |
Operational
| Director/Board Member | 150 |
| Corporate Officer/Principal | 60 |
| Independent Dir/Board Member | 49 |
| Chairman | 33 |
| Chief Executive Officer | 26 |
Most connected contacts
| Insiders | |
|---|---|
| Mark Leschly | 36 |
| Anders Hove | 31 |
| Paul Berns | 28 |
| Wendell Wierenga | 23 |
| Douglas Giordano | 22 |
| Keith Leonard | 20 |
| Lucy Shapiro | 18 |
| Richard Markham | 17 |
| Zhi Hong | 16 |
| Geoffrey Parker | 16 |
| William Rieflin | 16 |
| David Perry | 13 |
| Graeme Bell | 9 |
| Vincent Ippolito | 9 |
| Eric Easom | 9 |
- Stock Market
- Insiders
- Carmen R. Rodriguez
- Company connections